Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, according to published results.

Moderna Inc.’s experimental flu shot made with mRNA technology will be reviewed by a Food and Drug Administration advisory ...

After getting slapped with a surprise refuse-to-file letter signed by former CBER Director Vinay Prasad, Moderna’s flu ...

Moderna’s experimental mRNA flu shot will be reviewed by a Food and Drug Administration (FDA) advisory panel next month, a ...

Presented by Coalition to Strengthen America’s Healthcare{beacon} Health Care Health Care The Big Story Moderna’s mRNA flu ...

On May 6, 2026, Moderna’s board amended its bylaws to require Securities Act of 1933 lawsuits be filed exclusively in US ...

Learn more The open-session hearing comes just weeks ahead of the agency’s Aug. 5 target date to decide on the vaccine’s ...

May 21 (Reuters) - The U.S. FDA said on Thursday it would hold a meeting of outside experts next month to review Moderna's ...

After a large trial showed stronger protection, regulators are weighing whether Moderna’s mRNA vaccine could become a U.S. first.

A new study led by researchers from Maccabi Healthcare Services in Isreal suggests that flu vaccination rates among older ...

There are some unusual symptoms being reported with a new and mutated flu variant quickly spreading in the U.S. ahead of holiday gatherings. According to Dr. Juanita Mora, the national spokesperson ...

Defense Secretary Pete Hegseth says the U.S. military will no longer mandate the flu vaccine for American troops. He cited “medical autonomy” and religious freedom.